Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

B. Mikudina; T. Péter; B Nagy; K Horváth

doi:10.1016/j.jval.2014.08.2270

Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

Value in Health ◽

10.1016/j.jval.2014.08.2270 ◽

2014 ◽

Vol 17 (7) ◽

pp. A633-A634

Author(s):

B. Mikudina ◽

T. Péter ◽

B Nagy ◽

K Horváth

Keyword(s):

Cost Effectiveness ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Standard Of Care ◽

Model Adaptation ◽

Effectiveness Model ◽

Global Cost ◽

Metastatic Basal Cell Carcinoma

Download Full-text

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: retrospective real‐life data

Dermatologic Therapy ◽

10.1111/dth.15122 ◽

2021 ◽

Author(s):

Mustafa Gürbüz ◽

İzzet DoĞan ◽

Erman AkkuŞ ◽

Hande ErmiŞ ◽

Güngör Utkan ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Real Life ◽

Life Data ◽

Real Life Data ◽

Metastatic Basal Cell Carcinoma

Download Full-text

26200 Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.377 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB89

Author(s):

Michael Migden ◽

Aaron S. Farberg ◽

James Spencer ◽

Felix Kiecker ◽

Alexander Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Tumor Burden ◽

Metastatic Basal Cell Carcinoma ◽

Advanced Basal Cell Carcinoma

Download Full-text

Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14542 ◽

2017 ◽

Vol 32 (3) ◽

pp. 372-381 ◽

Cited By ~ 54

Author(s):

J.T. Lear ◽

M.R. Migden ◽

K.D. Lewis ◽

A.L.S. Chang ◽

A. Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Phase 2 ◽

Efficacy And Safety ◽

Term Efficacy ◽

Metastatic Basal Cell Carcinoma ◽

Randomized Phase 2

Download Full-text

Abstract LB-138: Efficacy data of GDC-0449, a systemic Hedgehog pathway antagonist, in a first-in-human, first-in-class Phase I study with locally advanced, multifocal or metastatic basal cell carcinoma patients

10.1158/1538-7445.am2008-lb-138 ◽

2008 ◽

Cited By ~ 5

Author(s):

Daniel D Von Hoff ◽

Charles M Rudin ◽

Patricia M LoRusso ◽

Mitesh J Borad ◽

Ronald L Korn ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Basal Cell ◽

Phase I Study ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Efficacy Data ◽

Metastatic Basal Cell Carcinoma

Download Full-text

A 12-month update of BOLT, a phase 2, randomized, double-blind study of sonidegib (LDE225) in patients with locally advanced or metastatic basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.729 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB178

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Blind Study ◽

Double Blind Study ◽

Phase 2 ◽

Double Blind ◽

Metastatic Basal Cell Carcinoma

Download Full-text

Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma

Current Pharmaceutical Design ◽

10.2174/1381612822666161208100325 ◽

2017 ◽

Vol 23 (4) ◽

pp. 655-659 ◽

Cited By ~ 12

Author(s):

Bita Esmaeli ◽

Vivian Yin

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Metastatic Basal Cell Carcinoma

Download Full-text

PSN4 COST-EFFECTIVENESS MODEL OFALDARA™ (IMIQUIMOD) CREAM, 5% IN SUPERFICIAL BASAL CELL CARCINOMA IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)67589-4 ◽

2005 ◽

Vol 8 (6) ◽

pp. A144 ◽

Cited By ~ 1

Author(s):

E De Cock ◽

MJ Nuijten ◽

A Hollestein ◽

L Hamel-Gariépy

Keyword(s):

Cost Effectiveness ◽

Basal Cell Carcinoma ◽

The Netherlands ◽

Cell Carcinoma ◽

Basal Cell ◽

Imiquimod Cream ◽

Effectiveness Model ◽

Superficial Basal Cell Carcinoma

Download Full-text

Drug‐related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma

Australasian Journal of Dermatology ◽

10.1111/ajd.13205 ◽

2019 ◽

Vol 61 (2) ◽

pp. 176-177

Author(s):

Matthew Gibson ◽

Dedee Frances Murrell

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Effects ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Metastatic Basal Cell Carcinoma

Download Full-text

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)70100-2 ◽

2015 ◽

Vol 16 (6) ◽

pp. 716-728 ◽

Cited By ~ 175

Author(s):

Michael R Migden ◽

Alexander Guminski ◽

Ralf Gutzmer ◽

Luc Dirix ◽

Karl D Lewis ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Trial ◽

Metastatic Basal Cell Carcinoma ◽

Different Doses

Download Full-text

The use of Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.1160 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB294

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Hedgehog Pathway ◽

Metastatic Basal Cell Carcinoma

Download Full-text